DV
Dividend Vision

ALUR — Allurion Technologies, Inc.

Allurion Technologies, Inc. (ALUR)

Total return is -99.9% over the past 5.3 years, 201.5 points behind SPY at 101.6%. Its deepest 1-year drawdown was 94.0%.

Allurion Technologies is a medical device and digital health company that develops a weight loss platform featuring the Allurion Smart Capsule, a swallowable intragastric balloon, paired with the Allurion Virtual Care Suite for remote monitoring and behavioral support. The company does not currently distribute dividends. Allurion appeals to growth-oriented investors in the healthcare technology sector, as the company focuses on expanding its weight loss solutions across Spain, France, Turkey, and other markets.

ALUR key facts

Asset type
Stock
Asset class
Equity
Inception date
03/29/2021
Last close
$4.98
Market cap
$4,001,668
Average volume
1097.0
Beta
-0.173
Payout ratio
0.0
Forward P/E
1.0048
EPS
$-3.96